Adare Pharma Solutions — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Adare Pharma Solutions is a specialized CDMO with a strong focus on advanced oral drug delivery technologies. It operates a global network of seven state-of-the-art facilities, offering end-to-end services from product development through commercial manufacturing. The company's core expertise lies in patient-centric solutions designed to improve adherence, bioavailability, and dosing convenience. Its proprietary technology platforms address key industry challenges for both branded and generic pharmaceuticals.

Drug Delivery

Technology Platform

Proprietary platforms for taste masking (Microcaps®), customized drug release (Diffucaps®, Diffutab®), solubility enhancement (SS-SD technology), and patient-centric dosing (AdvaTab® ODT, Mini Tablet System).

Opportunities

Growing demand for solubility enhancement solutions for poorly soluble drug candidates and increased focus on patient-centric dosage forms (e.g., pediatric, geriatric, ODTs) present significant market opportunities.

Expansion into full-service offerings like packaging and logistics provides additional revenue streams and deepens client relationships.

Risk Factors

Revenue is tied to client pipeline success, exposing the business to pharmaceutical R&D cycles.

The CDMO market is highly competitive, and operational complexity is high due to global manufacturing and stringent regulatory requirements across multiple jurisdictions.

Competitive Landscape

Adare competes in the specialized CDMO space focused on oral drug delivery against companies like Catalent, Lonza (Capsugel), Colorcon, and other niche formulation experts. Its differentiation lies in its specific, combinable technology platforms and deep expertise in taste masking and multiparticulate release systems.

More companies in Drug Delivery & Formulation →More companies in Italy →